The Potential for AI to Impact Dental Care
In an interview, VideaHealth CEO Florian Hillen says a new funding round will focus on enhancing customer service, expanding partnerships, and developing new AI-driven administrative tools
2025
Read More
AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal
FibroGen secured regulatory approvals for roxadustat in China and Europe, but the FDA rejected the drug and asked for another clinical trial. By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially resuming development of roxadustat in another indication. The post AstraZeneca Secures China Rights to Anemia…
The Future of Drug Discovery is 3D
Improving the identification and validation of disease-specific drug targets in a cell-type and patient-specific manner early on will not only reduce the failure rate and cost that is so inherent in current drug development processes but also allow the development of more effective precision medicines, improving patient outcomes. The post The Future of Drug Discovery…
The Outlook for PEPFAR in 2025 and Beyond
PEPFAR, the U.S. global HIV/AIDS program, is – for the first time in its two-decade history – facing significant challenges that could impede its ability to fulfill its mission. This policy brief provides an overview of recent events and ongoing challenges facing the program.
How Can Healthcare Practices Cut Waste?
[Sponsored] A webinar sponsored by Elation Health will offer insights and share tips on helping practices run more efficiently. It’s scheduled for Wednesday, February 26 at 3 pm ET. The post How Can Healthcare Practices Cut Waste? appeared first on MedCity News.
Improving the patient experience – why it matters
No matter how much the healthcare industry evolves — whether through new legislative priorities or advances in AI and automation — one thing remains constant: the patient experience matters. Patients expect quality care, quickly. For five years running, timely access has been a top priority for patients, according to Experian Health’s State of Patient Access…
An Ice Rink To Fight Opioid Crisis: Drug-Free Fun vs. Misuse of Settlement Cash
A Kentucky county nestled in the heart of Appalachia, where the opioid crisis has wreaked devastation for decades, spent $15,000 of its opioid settlement money on an ice rink. That amount wasn’t enough to solve the county’s troubles, but it could have bought 333 kits of Narcan, a medication that can reverse opioid overdoses. Instead,…
Healthcare Economist named a top 100 Economics blog
In Feedspot’s 2025 ranking of economics blogs, Healthcare Economist was once again ranked in the top 100 (#44). I was also ranked as the #4 top health economics blog of 2025 as well. You can see their full economics blog rankings here.
Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult
Altitude Lab Fund will provide pre-seed funding for early-stage startups affected by changes to grant programs administered by the National Institutes of Health. Accepted applicants will be admitted to Altitude Lab, the Salt Lake City biotech accelerator formed by Recursion Pharmaceuticals. The post Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap…
How Tampa General Hospital’s Partnership with Palantir Is Shortening Its Innovation Timelines
Palantir is poised to have a significant impact on the healthcare sector, said Scott Arnold, CIO and chief of innovation at Tampa General Hospital. Partnering with the tech company has allowed Tampa General to “solve problems in hours and days instead of months and years,” he remarked. The post How Tampa General Hospital’s Partnership with…